0
0

A bill to amend title XVIII of the Social Security Act to provide for coverage under the medicare program of oral drugs to reduce serum phosphate levels in dialysis patients with end-stage renal disease.

1/16/2023, 5:47 PM

Congressional Summary of S 1304

Amends title XVIII (Medicare) of the Social Security Act (SSA), as amended by the Medicare, Medicaid, and SCHIP Benefits Improvement and Protection Act of 2000, to provide Medicare coverage of certain oral drugs for reducing serum phosphate levels in dialysis patients with end-stage renal disease.

Read the Full Bill

Current Status of Bill S 1304

Bill S 1304 is currently in the status of Bill Introduced since August 2, 2001. Bill S 1304 was introduced during Congress 107 and was introduced to the Senate on August 2, 2001.  Bill S 1304's most recent activity was Read twice and referred to the Committee on Finance. as of August 2, 2001

Bipartisan Support of Bill S 1304

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
5
Democrat Cosponsors
4
Republican Cosponsors
0
Unaffiliated Cosponsors
1

Policy Area and Potential Impact of Bill S 1304

Primary Policy Focus

Health

Potential Impact Areas

- Drug therapy
- Kidney diseases
- Medicare
- Social Welfare

Alternate Title(s) of Bill S 1304

A bill to amend title XVIII of the Social Security Act to provide for coverage under the medicare program of oral drugs to reduce serum phosphate levels in dialysis patients with end-stage renal disease.
A bill to amend title XVIII of the Social Security Act to provide for coverage under the medicare program of oral drugs to reduce serum phosphate levels in dialysis patients with end-stage renal disease.

Comments